Key Material For Diagnostic Agent Temporarily Stops Exporting To Japan
This article was originally published in PharmAsia News
Executive Summary
Due to a production halt caused by reactor trouble at Atomic Energy of Canada Ltd, molybdenum 99, a key material for cancer and vascular diagnostic agents, will not be exported to Japan temporarily. Japan Radioisotope Association May 26 notified medical facilities nationwide. The production halt is expected to last for more than one month. AECL accounts for over half of worldwide molybdenum 99 production. (Click here for more - Japanese language